Focal glomerulosclerosis in the remnant kidney model - An inflammatory disease mediated by cytokines

Nephrology Dialysis Transplantation

Volumn 12, Issue 3, 1997, Pages 430-437

  Schiller, Brigitte ^a,c   Moran, John ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Growth factors; Monocyte chemoattractant protein 1; Remnant kidney model; Transforming growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY DISTAL TUBULE; NEPHRECTOMY; NEPHRITIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RAT;

ANIMALS; BLOTTING, NORTHERN; CHEMOKINE CCL2; CYTOKINES; DIET; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; KIDNEY; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031059111     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.3.430     Document Type: Article

References (52)

1. Klahr S, Schreiner O, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666
2. Lovett DH, Larsen A. Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. J Immunol 1988; 134: 1796-1801
3. Abboud HE, Poptic E, DiCorleto P. Production of platelet-derived growth factor-like protein by rat mesangial cells in culture. J Clin Invest 1987; 80: 675-683
4. McKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor-β. J Clin Invest 1989; 83: 1160-1167
5. Frank J, Engler-Blum G, Rodemann HP, Müller GA. Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1993; 1: 26-35
6. Hooke DH, Gee DC, Atkins RC. Leucocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987; 31: 964-973
7. Markovic-Lipkovski J, Müller CA, Risler T, Bohle A, Müller GA. Glomerular and interstitial infiltrates of mononuclear leukocytes in glomerulonephritis. Nephrol Dial Transplant 1990; 5: 10-17
8. Bohle A, Mackensen-Haen S, von Gise H, Grund KE, Wehrmann M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C, Müller G. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Path Res Pract 1990; 186: 135-144
9. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453-462
10. Ding G, Pesek-Diamond I, Diamond J. Cholesterol, macrophages, and gene expression of TGF-β and fibronectin during nephrosis. Am J Physiol 1993; 264: F577-F584
11. Nakamura T, Ebihara I, Fukui M et al. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. Clin Immunol Immunopathol 1993; 66: 33-42
12. Tamaki K, Okuda S, Takashi A et al. TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994; 45: 525-536
13. Sporn MB, Roberts AB. Peptide growth factors and inflammation, tissue repair and cancer. J Clin Invest 1986; 78: 329-332
14. Border W. Transforming growth factor-β and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 1994; 3: 54-58
15. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371-374
16. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-363
17. Okuda S, Nakamura T, Yamamoto T, Ruoslahti E, Border WA. Dietary protein restriction rapidly reduces transforming growth factor β1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 1991; 88: 9765-9769
18. Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H. Low protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 1993; 121: 224-234
19. Eddy AA. Protein restriction reduces transforming growth factor-β and interstitial fibrosis in nephrotic syndrome. Am J Physiol 1994; 266: F884-F893
20. Cattell V. Macrophages in acute glomerular inflammation (editorial review). Kidney Int 1994; 45: 945-952
21. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 1989; 35: 778-782
22. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326
23. Schreiner GF. The role of macrophages in glomerular injury. Semin Nephrol 1991; 11: 268-275
24. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Cr Rev Immunol 1992; 12: 17-46
25. Nelken NA, Coughlin SR, Gordon D, Valente AJ. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-1125
26. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis, Kidney Int 1988; 33: 917-924
27. Stahl RAK. Chemoattractive cytokines (chemokines) and immune renal injury. Nephrol Dial Transplant 1995; 10: 307-309
28. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brunner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-F93
29. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic disease. New Engl J Med 1982; 307: 652-659
30. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22: 1077-1083
31. Chromczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
32. Piechaczyk M, Blanchard JM, Marty L, Dani Ch, Panabieres F, El Sabouty S, Fort Ph, Jeanteur Ph. Posttranscriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nuc Acid Res 1984; 12: 6951-6963
33. Flanders KC, Thompson NL, Cissel DS, van Obergher-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J Cell Biol 1989; 108: 653-660
34. Hancock WW, Becker GJ, Atkins RC. A comparison of fixatives and immunohistochemical techniques for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol 1982; 78: 825-831
35. Hostetter TH, Rennke HG, Brenner BM. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kidney Dis 1982; 1: 310-314
36. Hostetter TH, Meyer TW, Rennke HG, Brenner BM: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986; 30: 509-517
37. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309
38. Van Goor H, Fidler V, Weening JJ, Grond J. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Lab Invest 1991; 64: 754-765
39. Safirstein R, Megyesi J, Saggi SJ et al. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: F1095-F1101
40. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC. Macrophages, monocyte chemoattractant peptide-1 and TGF-β in experimental hydronephrosis. Am J Physiol 1994; 266: F926-F933
41. Satriano J et al. Reactive oxygen species as 2nd messengers for activation of CSF-1 and MCP-1 in mesangial cells. J Am Soc Nephrol 1993; 4: 631 (abstract)
42. Border WA, Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992; 90: 1-7
43. Pimentel JL, Sundell CL, Wang S et al. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 1995; 48: 1233-1246
44. Johnson RJ. Cytokine networks and the pathogenesis of glomerulonephritis. J Lab Clin Med 1993; 121: 190-192
45. Muchaneta-Kubara EC, Sayed-Ahmed N, El Nahas AM. Subtotal nephrectomy: a mosaic of growth factors. Nephrol Dial Transpl 1995; 10: 320-327
46. Rosenberg ME, Chmielewski D, Hostetter TH. Effect of dietary protein on renin and angiotensinogen gene expression. J Clin Invest 1990; 85: 1144-1149
47. Don BR, Blake S, Hutchinson FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol 1989; 256: F711-F718
48. El Nahas AM, Masters-Thomas A, Brady SA, Farrington K, Wilkinson V, Hilson AJ, Varghese Z, Moorhead JF. Selective effect of low protein diets in chronic diseases. British Med Journal 1984; 289: 1337-1341
49. Agus D, Mann R, Cohn D et al. Inhibitory role of dietary protein restriction on the development and expression of immune-mediated antitubular basement membrane-induced tubulointerstitial nephritis in rats. J Clin Invest 1985; 76: 930-936
50. Khalil N, Berenznay O, Sporn MB, Greenberg AH. Macrophage production of transforming growth faclor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1999; 131: 836-843
51. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994; 153: 4733-4741
52. El Nahas AM. Pathways to renal fibrosis. Exp Nephrol 1995; 3: 71-75